August 17, 2026
Every time a doctor prescribes a medicine or a patient picks up a strip of tablets, they place their trust in something they can’t see: the manufacturing process behind that product. This is where WHO-GMP certified medicines make the difference. Healthcare professionals rarely get to inspect a production facility themselves, and patients almost never think about it at all. Yet this invisible layer of quality assurance is exactly what keeps medicines safe, consistent, and effective, batch after batch. At KRV Life Sciences, this standard sits at the core of how we choose our manufacturing partners, and in this article, we break down what the certification actually means and why it matters to everyone in the healthcare chain.
WHO-GMP stands for World Health Organization Good Manufacturing Practices. It is a globally recognised framework that governs how pharmaceutical products are manufactured, tested, and released. Rather than certifying a single product, WHO-GMP evaluates the manufacturing site and its processes — which is why the industry more accurately refers to a “WHO-GMP certified manufacturer” or a medicine “manufactured in a WHO-GMP-compliant facility.” A pharmaceutical company that holds this certification has demonstrated that its facility, systems, and personnel meet a consistent, internationally benchmarked quality standard.
The framework covers several critical areas, including:
Because WHO-GMP is applied consistently across these areas, it sets a considerably higher bar than a basic manufacturing licence. In India, for instance, licensed manufacturers must comply with Schedule M under the Drugs and Cosmetics Rules, 1945 — the country’s statutory GMP framework enforced by the CDSCO and State Drug Control Administrations. Schedule M compliance is mandatory and covers similar ground: premises, documentation, validation, and quality systems. However, certification against the WHO framework signals that a facility has been assessed against an internationally benchmarked standard, which matters enormously for companies exporting medicines or partnering with international stakeholders.
It’s also worth understanding what this certification does not cover. Schedule M compliance does not automatically mean a medicine is WHO-prequalified — WHO prequalification is a separate, product-specific assessment, distinct from facility-level manufacturing compliance. Knowing this difference helps healthcare professionals and pharmaceutical companies alike ask the right questions when evaluating a new supplier or generic medicine range.
For doctors, pharmacists, and other healthcare professionals, WHO-GMP certified medicines translate directly into confidence. When a manufacturer operates under WHO-GMP, every batch is produced under the same validated process, so the medicine prescribed today performs the same way as the one prescribed last month. This consistency reduces the risk of therapeutic failure caused by manufacturing variability.
Traceability is another major benefit. WHO-GMP-compliant facilities maintain detailed batch manufacturing records, from raw material intake through to final packaging. Consequently, if a quality concern ever arises, it can be traced back through the entire production chain quickly and accurately. This level of documentation also supports faster, more effective recall management, should it ever be needed.
Perhaps most importantly, working with a certified pharmaceutical company allows healthcare professionals to prescribe or recommend a product without needing to personally audit the manufacturer. Instead, they can rely on a globally recognised quality system that has already done that work. For a pharmaceutical marketing company like KRV, this is precisely why partnering only with WHO-GMP certified manufacturers is non-negotiable — it protects the credibility of every product we bring to market and supports our broader commitment to manufacturing compliance across the board.
Patients rarely see the inside of a manufacturing facility, and they shouldn’t have to. What they need is the assurance that the medicine they are taking is safe, effective, and exactly what it claims to be. WHO-GMP certified medicines provide that assurance quietly, in the background, through rigorous production and testing standards rather than marketing claims.
This matters even more in categories where dosage precision is critical, such as chronic disease management, where small inconsistencies between batches could affect long-term treatment outcomes. Additionally, strict WHO-GMP manufacturing compliance helps prevent contamination, mislabeling, and other production errors that could otherwise put patients at risk.
There’s also an affordability angle worth addressing directly. Many patients assume that higher quality automatically means higher cost. However, by partnering with efficient WHO-GMP certified manufacturers rather than building costly in-house facilities, pharmaceutical companies like KRV can deliver quality-assured, affordable generic medicines without cutting corners. In other words, WHO-GMP certified medicines prove that affordability and quality are not mutually exclusive — they simply require the right sourcing decisions.
KRV Life Sciences does not manufacture medicines directly. Instead, we partner exclusively with WHO-GMP certified third-party manufacturers, a model that lets us focus on what we do best — marketing, distribution, and building trusted relationships with healthcare professionals — while ensuring every product we distribute meets internationally recognised manufacturing standards.
Our partner selection process involves several layers of due diligence. Before onboarding any manufacturing partner, we verify current WHO-GMP certification status and cross-check it against relevant regulatory licences, including Schedule M compliance where applicable. We also review the manufacturer’s documentation practices, quality control systems, and track record for consistency. This isn’t a one-time check either; we maintain ongoing quality agreements and periodic reviews with our partners to ensure standards are upheld over time, not just at the point of onboarding.
This disciplined approach is reflected in one of our core proof points: 100% of KRV’s manufacturing partners hold WHO-GMP certification. As our Founder and Managing Director, Dr. Manoj Kumar Padidala, a Pharma D by training, has emphasised, this standard was never treated as optional. From the earliest days of building KRV, the decision was clear — the company would rather grow slowly with trusted, certified manufacturers than grow quickly with compromised quality. That principle continues to guide every partnership KRV forms today, whether we are evaluating a new supplier or expanding our therapeutic portfolio into a new state.
Right from the inception of KRV, my decision was clear — we would rather grow slowly with trusted, certified manufacturers than grow quickly with compromised quality. Quality standards were never treated as optional.
Dr. Manoj Kumar Padidala – Founder & Managing Director, KRV Life Sciences
As KRV Life Sciences continues expanding across Indian states, our commitment to sourcing WHO-GMP certified medicines remains the foundation of that growth. Trust, once built with healthcare professionals and patients, has to be maintained consistently — and that starts with the manufacturing standard behind every product. We believe that pharmaceutical marketing companies have a responsibility to look beyond price and reach, and instead prioritise the quality systems that protect the people who ultimately use these medicines.
Looking ahead, we also expect regulatory expectations in India to continue tightening, particularly as revised Schedule M provisions are phased in across the industry. Rather than treating compliance as a moving target, KRV intends to stay ahead of these changes by continuing to work only with manufacturers who already meet — or exceed — the higher international bar.
If you’re a healthcare professional evaluating a new pharmaceutical partner, or a pharmacy looking to stock reliable products, we invite you to learn more about KRV’s therapeutic portfolio and manufacturing partnerships.
Committed to Quality. Driven by Trust. That’s not just our tagline — it’s the standard behind every medicine we bring to market.
One Response